Using Mendelian randomization to determine causative factors in cardiovascular disease
JOURNAL OF INTERNAL MEDICINE (2013)
期刊
JOURNAL OF INTERNAL MEDICINE
卷 273, 期 1, 页码 44-47出版社
WILEY
关键词
资金
- Canadian Institutes of Health Research [MOP-79523, CTP-79853, MOP-13430] Funding Source: Medline
作者
我是这篇论文的作者
推荐
Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis
Liming Zhang, Yuxiang Wang, Li Qiu, Jian Wu
BMC MEDICINE (2022)
L-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study
Jie Zhao, Stephen Burgess, Bohan Fan, C. Mary Schooling
BMC MEDICINE (2022)
Genetically predicted circulating vitamin C in relation to cardiovascular disease
Shuai Yuan, Ju-Sheng Zheng, Amy M. Mason, Stephen Burgess, Susanna C. Larsson
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Associations of Arachidonic Acid Synthesis with Cardiovascular Risk Factors and Relation to Ischemic Heart Disease and Stroke: A Univariable and Multivariable Mendelian Randomization Study
Ting Zhang, Shiu-Lun Au Yeung, C. Mary Schooling
NUTRIENTS (2021)
Coffee Consumption and Cardiovascular Diseases: A Mendelian Randomization Study
Shuai Yuan, Paul Carter, Amy M. Mason, Stephen Burgess, Susanna C. Larsson
NUTRIENTS (2021)
Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies
Lei Hou, Hongkai Li, Shucheng Si, Yuanyuan Yu, Xiaoru Sun, Xinhui Liu, Ran Yan, Yifan Yu, Chuan Wang, Fan Yang, Qing Wang, Fuzhong Xue
ATHEROSCLEROSIS (2021)
Genetically Higher Level of Mannose Has No Impact on Cardiometabolic Risk Factors: Insight from Mendelian Randomization
Mohsen Mazidi, Abbas Dehghan, Maciej Banach
NUTRIENTS (2021)
Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study
Shuai Yuan, Amy M. Mason, Paul Carter, Stephen Burgess, Susanna C. Larsson
BMC MEDICINE (2021)
Genetically Predicted Insomnia in Relation to 14 Cardiovascular Conditions and 17 Cardiometabolic Risk Factors: A Mendelian Randomization Study
Xinhui Liu, Chuanbao Li, Xiaoru Sun, Yuanyuan Yu, Shucheng Si, Lei Hou, Ran Yan, Yifan Yu, Mingzhuo Li, Hongkai Li, Fuzhong Xue
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Evaluation of bi-directional causal association between depression and cardiovascular diseases: a Mendelian randomization study
Gloria Hoi-Yee Li, Ching-Lung Cheung, Albert Kar-Kin Chung, Bernard Man-Yung Cheung, Ian Chi-Kei Wong, Marcella Lei Yee Fok, Philip Chun-Ming Au, Pak-Chung Sham
PSYCHOLOGICAL MEDICINE (2022)
The associations of plasma phospholipid arachidonic acid with cardiovascular diseases: A Mendelian randomization study
Ting Zhang, Jie Zhao, C. Mary Schooling
EBIOMEDICINE (2021)
Mendelian randomization for cardiovascular diseases: principles and applications
Susanna C. Larsson, Adam S. Butterworth, Stephen Burgess
EUROPEAN HEART JOURNAL (2023)
Contribution of metabolic risk factors and lifestyle behaviors to cardiovascular disease: A mendelian randomization study
Yiming Jia, Rong Wang, Daoxia Guo, Lulu Sun, Mengyao Shi, Kaixin Zhang, Pinni Yang, Yuhan Zang, Yu Wang, Fanghua Liu, Yonghong Zhang, Zhengbao Zhu
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization
Zixiang Ye, Jingang Zheng
FRONTIERS IN GENETICS (2021)
Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank
Xiaomeng Zhang, Xue Li, Yazhou He, Philip J. Law, Susan M. Farrington, Harry Campbell, Ian P. M. Tomlinson, Richard S. Houlston, Malcolm G. Dunlop, Maria Timofeeva, Evropi Theodoratou
BRITISH JOURNAL OF CANCER (2022)
How reliable are polygenic risk scores for risk prediction in patients with heart disease?
Erin O. Jacob, Robert A. Hegele
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2023)
The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants
Shehan D. Perera, Jian Wang, Adam D. McIntyre, Jacqueline S. Dron, Robert A. Hegele, Cert Endo
JOURNAL OF CLINICAL LIPIDOLOGY (2023)
'Keep on keeping on': persistence with lipid-lowering treatment in familial hypercholesterolaemia
Robert A. Hegele
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)
The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
Pei Jun Zhao, Robert A. Hegele
CJC OPEN (2023)
Apolipoprotein C-II: a new look at an old protein
Robert A. Hegele
EUROPEAN HEART JOURNAL (2023)
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
Marina Cuchel, Frederick J. Raal, Robert A. Hegele, Khalid Al-Rasadi, Marcello Arca, Maurizio Averna, Eric Bruckert, Tomas Freiberger, Daniel Gaudet, Mariko Harada-Shiba, Lisa C. Hudgins, Meral Kayikcioglu, Luis Masana, Klaus G. Parhofer, Jeanine E. Roeters van Lennep, Raul D. Santos, Erik S. G. Stroes, Gerald F. Watts, Albert Wiegman, Jane K. Stock, Lale S. Tokgoezoglu, Alberico L. Catapano, Kausik K. Ray
EUROPEAN HEART JOURNAL (2023)
Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors
Catherine M. Spagnuolo, Robert A. Hegele
EXPERT OPINION ON PHARMACOTHERAPY (2023)
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts, Samuel S. Gidding, Robert A. Hegele, Frederick J. Raal, Amy C. Sturm, Laney K. Jones, Mitchell N. Sarkies, Khalid Al-Rasadi, Dirk J. Blom, Magdalena Daccord, Sarah D. de Ferranti, Emanuela Folco, Peter Libby, Pedro Mata, Hapizah M. Nawawi, Uma Ramaswami, Kausik K. Ray, Claudia Stefanutti, Shizuya Yamashita, Jing Pang, Gilbert R. Thompson, Raul D. Santos
NATURE REVIEWS CARDIOLOGY (2023)
Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia
Ahsen Chaudhry, Mark Trinder, Kristin Vesely, Lubomira Cermakova, Linda Jackson, Jian Wang, Robert A. Hegele, Liam R. Brunham
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2023)
Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management
Iulia Iatan, G. B. John Mancini, Eunice Yeoh, Robert A. Hegele
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2023)
Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada
Jean Lachaine, Jean -Nicolas Charron, Jean C. Gregoire, Robert A. Hegele, Lawrence A. Leiter
CLINICOECONOMICS AND OUTCOMES RESEARCH (2023)
Low cholesterol states: clinical implications and management
Praneet K. K. Gill, Robert A. A. Hegele
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2023)
Academic-Industry Partnerships: Transparency, Potential Conflict of Interest, and Communicating State-of-the-Art Technologies
Ann Marie Schmidt, Mary G. Sorci-Thomas, Yabing Chen, Robert A. Hegele
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)
Illuminating the full spectrum of APOE variation
Robert A. Hegele
ATHEROSCLEROSIS (2023)
Polygenic risk for triglyceride levels in the presence of a high impact rare variant
Shengjie Ying, Tracy Heung, Bhooma Thiruvahindrapuram, Worrawat Engchuan, Yue Yin, Christina Blagojevic, Zhaolei Zhang, Robert A. Hegele, Ryan K. C. Yuen, Anne S. Bassett
BMC MEDICAL GENOMICS (2023)